$DORM
Dorman Products, Inc.

2016 Q1 Form 10-Q Financial Statement

#000119312516562992 Filed on April 28, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $208.1M $188.5M
YoY Change 10.44% 2.7%
Cost Of Revenue $127.6M $115.6M
YoY Change 10.36% 3.32%
Gross Profit $80.59M $72.89M
YoY Change 10.56% 1.75%
Gross Profit Margin 38.72% 38.68%
Selling, General & Admin $41.66M $39.24M
YoY Change 6.17% 13.1%
% of Gross Profit 51.69% 53.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.500M $3.600M
YoY Change 25.0% 25.87%
% of Gross Profit 5.58% 4.94%
Operating Expenses $41.66M $39.24M
YoY Change 6.17% 13.1%
Operating Profit $38.93M $33.65M
YoY Change 15.69% -8.92%
Interest Expense $57.00K $52.00K
YoY Change 9.62% 33.33%
% of Operating Profit 0.15% 0.15%
Other Income/Expense, Net
YoY Change
Pretax Income $38.87M $33.60M
YoY Change 15.7% -8.96%
Income Tax $14.20M $12.26M
% Of Pretax Income 36.54% 36.49%
Net Earnings $24.67M $21.34M
YoY Change 15.61% -9.39%
Net Earnings / Revenue 11.85% 11.32%
Basic Earnings Per Share $0.71 $0.60
Diluted Earnings Per Share $0.71 $0.60
COMMON SHARES
Basic Shares Outstanding 34.68M shares 35.54M shares
Diluted Shares Outstanding 34.73M shares 35.64M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $87.00M $64.60M
YoY Change 34.67% 0.94%
Cash & Equivalents $86.98M $64.60M
Short-Term Investments
Other Short-Term Assets $2.700M $27.90M
YoY Change -90.32% 16.74%
Inventory $187.6M $183.0M
Prepaid Expenses
Receivables $207.4M $201.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $484.7M $476.7M
YoY Change 1.68% 6.08%
LONG-TERM ASSETS
Property, Plant & Equipment $88.43M $84.46M
YoY Change 4.7% 21.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.23M $14.07M
YoY Change 43.78% 515.09%
Total Long-Term Assets $146.5M $128.5M
YoY Change 14.03% 26.17%
TOTAL ASSETS
Total Short-Term Assets $484.7M $476.7M
Total Long-Term Assets $146.5M $128.5M
Total Assets $631.2M $605.2M
YoY Change 4.3% 9.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $52.26M $60.48M
YoY Change -13.59% 3.73%
Accrued Expenses $36.60M $31.37M
YoY Change 16.67% 8.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $92.49M $96.07M
YoY Change -3.73% 5.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.572M $4.462M
YoY Change 24.88% -11.13%
Total Long-Term Liabilities $5.572M $4.462M
YoY Change 24.88% -11.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $92.49M $96.07M
Total Long-Term Liabilities $5.572M $4.462M
Total Liabilities $98.06M $100.5M
YoY Change -2.46% 4.59%
SHAREHOLDERS EQUITY
Retained Earnings $490.0M $438.3M
YoY Change 11.79% 11.64%
Common Stock $43.19M $44.36M
YoY Change -2.64% 12052.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $533.2M $482.6M
YoY Change
Total Liabilities & Shareholders Equity $631.2M $605.2M
YoY Change 4.3% 9.79%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $24.67M $21.34M
YoY Change 15.61% -9.39%
Depreciation, Depletion And Amortization $4.500M $3.600M
YoY Change 25.0% 25.87%
Cash From Operating Activities $23.90M $23.80M
YoY Change 0.42% 114.41%
INVESTING ACTIVITIES
Capital Expenditures $5.598M $5.749M
YoY Change -2.63% -17.97%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.600M -$5.700M
YoY Change -1.75% -18.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00M -1.100M
YoY Change 809.09% 57.14%
NET CHANGE
Cash From Operating Activities 23.90M 23.80M
Cash From Investing Activities -5.600M -5.700M
Cash From Financing Activities -10.00M -1.100M
Net Change In Cash 8.300M 17.00M
YoY Change -51.18% 400.0%
FREE CASH FLOW
Cash From Operating Activities $23.90M $23.80M
Capital Expenditures $5.598M $5.749M
Free Cash Flow $18.30M $18.05M
YoY Change 1.39% 341.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47656000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.86
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
43242 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
34.49
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34863396 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34863396 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42799000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10970000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
518036000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5259000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63967000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23633000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
474888000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
621865000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
349000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
92487000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98570000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18740000
CY2015Q4 us-gaap Assets
Assets
621865000
CY2015Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
78533000
CY2015Q4 us-gaap Inventory Net
InventoryNet
193725000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
203923000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87046000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
112012000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
478633000
CY2015Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29889000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2326000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78659000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7557000
CY2015Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
3180000
CY2015Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
86986000
CY2015Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
335900000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64599000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
86684 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.56
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
135078 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
41.08
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34745761 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
40000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34745761 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.86
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42841000
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3629000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
533150000
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5572000
CY2016Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1900000
CY2016Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1400000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
52262000
CY2016Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36596000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
489962000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
631209000
CY2016Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
200000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
347000
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1865320
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20226000
CY2016Q1 us-gaap Assets
Assets
631209000
CY2016Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
66396000
CY2016Q1 us-gaap Inventory Net
InventoryNet
187586000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
207395000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88429000
CY2016Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
117601000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
484691000
CY2016Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29864000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2732000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86978000
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7999000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2420860
CY2016Q1 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
3589000
CY2016Q1 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
93223000
CY2016Q1 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
355200000
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34742221 shares
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
23804000
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35643000 shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
101000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35542000 shares
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5749000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
21339000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
188474000
CY2015Q1 us-gaap Interest Paid
InterestPaid
73000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-633000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
33652000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9515000
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1422000
CY2015Q1 us-gaap Gross Profit
GrossProfit
72893000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4883000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33600000
CY2015Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2746000
CY2015Q1 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-1700000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12261000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
340000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16943000
CY2015Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
3618000
CY2015Q1 us-gaap Interest Expense
InterestExpense
52000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5749000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1112000
CY2015Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-927000
CY2015Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3906000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
939000
CY2015Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
132900000
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39241000
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
115581000
CY2015Q1 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
0
CY2015Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
300000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000
CY2015Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
1230000
CY2015Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
118000
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
23914000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
97898 shares
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73000 shares
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000868780
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
240 shares
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
5822 shares
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
41.59
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34734000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
37.58
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
56000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
46684 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34678000 shares
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-26
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
18.94
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
43.72
CY2016Q1 dei Trading Symbol
TradingSymbol
DORM
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2016Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
CY2016Q1 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
0
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5598000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
24671000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
208148000
CY2016Q1 us-gaap Interest Paid
InterestPaid
70000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
405000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
38931000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6139000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1487000
CY2016Q1 us-gaap Gross Profit
GrossProfit
80594000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4468000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38874000
CY2016Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2568000
CY2016Q1 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
-2500000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14203000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
440000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8319000
CY2016Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4499000
CY2016Q1 us-gaap Interest Expense
InterestExpense
57000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5598000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-9997000
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-442000
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5901000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11930000
CY2016Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
135200000
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41663000
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
127554000
CY2016Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
400000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
996000
CY2016Q1 dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
CY2016Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
9986000
CY2016Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-11000

Files In Submission

Name View Source Status
0001193125-16-562992-index-headers.html Edgar Link pending
0001193125-16-562992-index.html Edgar Link pending
0001193125-16-562992.txt Edgar Link pending
0001193125-16-562992-xbrl.zip Edgar Link pending
d181218d10q.htm Edgar Link pending
d181218dex311.htm Edgar Link pending
d181218dex312.htm Edgar Link pending
d181218dex32.htm Edgar Link pending
dorm-20160326.xml Edgar Link completed
dorm-20160326.xsd Edgar Link pending
dorm-20160326_cal.xml Edgar Link unprocessable
dorm-20160326_def.xml Edgar Link unprocessable
dorm-20160326_lab.xml Edgar Link unprocessable
dorm-20160326_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending